{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:40:46Z","timestamp":1733874046632,"version":"3.30.1"},"reference-count":41,"publisher":"CAIRN","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,22]]},"abstract":"<jats:p>Le tabac chauff\u00e9 (TC), nouveau produit du tabac, est pr\u00e9sent\u00e9 par l\u2019industrie du tabac comme une alternative efficace et s\u00fbre \u00e0 la cigarette. M\u00eame si les quantit\u00e9s de compos\u00e9s nocifs pour la sant\u00e9 \u00e9mises par le TC sont inf\u00e9rieures \u00e0 celles trouv\u00e9es dans la fum\u00e9e de cigarette, cette diminution d\u2019exposition ne peut \u00eatre assimil\u00e9e \u00e0 une r\u00e9duction des risques. Aucune \u00e9tude n\u2019a apport\u00e9 la preuve que le passage de la cigarette au TC r\u00e9duisait le risque des maladies li\u00e9es au tabac. Le TC ne peut pas \u00eatre consid\u00e9r\u00e9 comme un produit de sevrage de la cigarette et a m\u00eame \u00e9t\u00e9 con\u00e7u comme un produit pour entrer dans la consommation de tabac ou y revenir. Pour faire la promotion de ce produit, l\u2019industrie du tabac exploite essentiellement le concept de r\u00e9duction des risques et, \u00e0 ce titre, essaie dans sa communication commerciale de cr\u00e9er la confusion entre le TC et la cigarette \u00e9lectronique alors que ces deux produits n\u2019ont rien \u00e0 voir. Cette promotion s\u2019appuie, d\u2019une part, sur les donn\u00e9es d\u2019\u00e9tudes internes contradictoires avec celles d\u2019\u00e9tudes ind\u00e9pendantes, d\u2019autre part, de fa\u00e7on ill\u00e9gale, sur les r\u00e9seaux sociaux et une communication en contradiction avec les avis des autorit\u00e9s de r\u00e9gulation. Le TC est un nouveau leurre de l\u2019industrie du tabac, destin\u00e9 \u00e0 assurer le maintien de ses profits dans un monde qui s\u2019\u00e9loigne de la cigarette \u00ab\u00a0traditionnelle\u00a0\u00bb. Il doit \u00eatre formellement d\u00e9conseill\u00e9, tant aux non-fumeurs qu\u2019aux fumeurs.<\/jats:p>","DOI":"10.3917\/spub.pr1.0023","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:54:10Z","timestamp":1700668450000},"page":"61-67","source":"Crossref","is-referenced-by-count":1,"title":["Le tabac chauff\u00e9 est-il un outil de r\u00e9duction des risques\u00a0?"],"prefix":"10.3917","volume":"Vol. 35","author":[{"given":"Daniel","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2273","reference":[{"key":"rb1","unstructured":"1. IHRA. Qu\u2019est-ce que la r\u00e9duction des risques et m\u00e9faits\u00a0? [En ligne]. IHRA; 2010. 2 p. Disponible sur\u00a0:https:\/\/www.hri.global\/files\/2010\/06\/01\/Briefing_What_is_HR_French.pdf"},{"key":"rb2","unstructured":"2. HAS. Arr\u00eater de fumer et ne pas rechuter\u00a0: la recommandation 2014 de la HAS. Questions\/R\u00e9ponses\u00a0: sevrage tabagique [En ligne]. HAS; 2014. 4 p. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2014-01\/question_reponse_sevrage_tabagique.pdf"},{"key":"rb3","unstructured":"3. Guignard R, Richard JB, Pasquereau A, Andler R, Arwidson P, Smadja O, et al.; le groupe Barom\u00e8tre sant\u00e9 2017. Tentatives d\u2019arr\u00eat du tabac au dernier trimestre 2016 et lien avec Mois sans tabac\u00a0: premiers r\u00e9sultats observ\u00e9s dans le Barom\u00e8tre sant\u00e9 2017. Bull Epid\u00e9miol Hebd. 15 f\u00e9v 2018;(14-15):298-303."},{"key":"rb4","doi-asserted-by":"crossref","unstructured":"4. Kotseva K, Wood D, De Bacquer D, De Backer G, Ryd\u00e9n L, Jennings C, et al. EUROASPIRE IV: A European Society of Cardiology Survey on the Lifestyle, Risk Factor and Therapeutic Management of Coronary Patients from 24 European Countries. Eur J Prev Cardiol. f\u00e9v 2016;23(6):636-48.","DOI":"10.1177\/2047487315569401"},{"key":"rb5","doi-asserted-by":"crossref","unstructured":"5. Aboyans V, Pineta P, Lacroix Ph, Laskar M. Knowledge and Management of Smoking-Cessation Strategies Among Cardiologists in France: A Nationwide Survey. Arch Cardiovasc Dis. mars 2009;102(3):193-9.","DOI":"10.1016\/j.acvd.2009.01.005"},{"key":"rb6","unstructured":"6. Diethelm P. Les nouveaux produits du tabac et de la nicotine vus \u00e0 travers le prisme du march\u00e9. La Lettre du psychiatre. mars 2020;22(1):14-9."},{"key":"rb7","unstructured":"7. Royal College of Physicians. Nicotine Without Smoke: Tobacco Harm Reduction [En ligne]. 2016 [Cit\u00e9 le 02\/06\/2023]. Disponible sur\u00a0: https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/nicotine-without-smoke-tobacco-harm-reduction"},{"key":"rb8","unstructured":"8. PMI Science. Philip Morris International. See How Heated Tobacco Product Aerosol Differs From Cigarette Smoke [En ligne]. [Cit\u00e9 le 02\/06\/2023] Disponible sur\u00a0: https:\/\/www.pmiscience.com\/en\/"},{"key":"rb9","doi-asserted-by":"crossref","unstructured":"9. Bekki K, Inaba Y, Uchiyama S, Kunugita N. Comparison of Chemicals in Mainstream Smoke in Heat-Not-Burn Tobacco and Combustion Cigarettes. J UOEH. 2017;39(3):201-7.","DOI":"10.7888\/juoeh.39.201"},{"key":"rb10","doi-asserted-by":"crossref","unstructured":"10. Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name. JAMA Intern Med. 2017;177(7):1050-2.","DOI":"10.1001\/jamainternmed.2017.1419"},{"key":"rb11","doi-asserted-by":"crossref","unstructured":"11. Uguna CN, Snape CE. Should IQOS Emissions Be Considered as Smoke and Harmful to Health? A Review of the Chemical Evidence. ACS Omega. juin 2022;7(26): 22111-24.","DOI":"10.1021\/acsomega.2c01527"},{"key":"rb12","doi-asserted-by":"crossref","unstructured":"12. St Helen G, Jacob Iii P, Nardone N, Benowitz NL. IQOS: Examination of Philip Morris International\u2019s Claim of Reduced Exposure. Tob Control. nov 2018; 27(Suppl_1):s30-s36.","DOI":"10.1136\/tobaccocontrol-2018-054321"},{"key":"rb13","doi-asserted-by":"crossref","unstructured":"13. Cancelada L, Sleiman M, Tang X, Russell ML, Montesinos VN, Litter MI, et al. Heated Tobacco Products: Volatile Emissions and Their Predicted Impact on Indoor Air Quality. Environ Sci Technol. juill 2019; 53(13):7866-76.","DOI":"10.1021\/acs.est.9b02544"},{"key":"rb14","doi-asserted-by":"crossref","unstructured":"14. Sutanto E, Miller C, Smith DM, O\u2019Connor RJ, Quah ACK, Hyland A, et al. Concurrent Daily and Non-Daily Use of Heated Tobacco Products with Combustible Cigarettes: Findings from the 2018 ITC Japan Survey. Int J Environ Res Public Health. mars 2020;17(6):2098.","DOI":"10.3390\/ijerph17062098"},{"key":"rb15","doi-asserted-by":"crossref","unstructured":"15. Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol. 22 sept 2015;66(12):1378-91.","DOI":"10.1016\/j.jacc.2015.07.037"},{"key":"rb16","doi-asserted-by":"crossref","unstructured":"16. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low Cigarette Consumption and Risk of Coronary Heart Disease and Stroke: Meta-Analysis of 141 Cohort Studies in 55 Study Reports. BMJ. 2018;360:j5855.","DOI":"10.1136\/bmj.j5855"},{"key":"rb17","doi-asserted-by":"crossref","unstructured":"17. Jeong SM, Jeon KH, Shin DW, Han K, Kim D, Park SH, et al. Smoking Cessation, But Not Reduction, Reduces Cardiovascular Disease Incidence. Eur Heart J. 21 oct 2021;42(40):4141-53.","DOI":"10.1093\/eurheartj\/ehab578"},{"key":"rb18","doi-asserted-by":"crossref","unstructured":"18. Choi S, Lee K, Park SM. Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study. Circulation. 9 nov 2021;144(19):1528-38.","DOI":"10.1161\/CIRCULATIONAHA.121.054967"},{"key":"rb19","unstructured":"19. PMI. Section 2.7 Executive Summary [En ligne]. Philip Morris Products S.A. \/ PMI Research & Development; 2017. 208 p. Disponible sur\u00a0: https:\/\/www.fda.gov\/media\/105437\/download"},{"key":"rb20","doi-asserted-by":"crossref","unstructured":"20. Berthet A, Jacot-Sadowski I, Z\u00fcrcher K, Guenin V, Gendre A, Auer R, et al. Produits du tabac \u00ab\u00a0chauff\u00e9\u00a0\u00bb\u00a0: que faut-il savoir\u00a0? Rev Med Suisse. 31 oct 2018;14(625):1935-41.","DOI":"10.53738\/REVMED.2018.14.625.1935"},{"key":"rb21","unstructured":"21. Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat-Not-Burn Tobacco Products: Concerns From the Italian Experience. Tob Control. janv 2019;28(1):113-4."},{"key":"rb22","doi-asserted-by":"crossref","unstructured":"22. Tattan-Birch H, Hartmann-Boyce J, Kock L, Simonavicius E, Brose L, Jackson S, et al. Heated Tobacco Products for Smoking Cessation and Reducing Smoking Prevalence. Cochrane Database Syst Rev. 6 janv 2022;1(1):CD013790.","DOI":"10.1002\/14651858.CD013790.pub2"},{"key":"rb23","doi-asserted-by":"crossref","unstructured":"23. Odani S, Tsuno K, Agaku IT, Tabuchi T. Heated Tobacco Products Do Not Help Smokers Quit Or Prevent Relapse: A Longitudinal Study in Japan. Tob Control. 27 f\u00e9v 2023; tc-2022-057613.","DOI":"10.1136\/tc-2022-057613"},{"key":"rb24","doi-asserted-by":"crossref","unstructured":"24. Auer R, Diethelm P, Berthet A. Heating Tobacco Sticks Instead of Combusting Conventional Cigarettes and Future Heart Attacks: Still Smoke, and Risk. Circulation. 8 nov 2021;144:1539-42.","DOI":"10.1161\/CIRCULATIONAHA.121.056959"},{"key":"rb25","doi-asserted-by":"crossref","unstructured":"25. Dusautoir R, Zarcone G, Verriele M, Gar\u00e7on G, Fronval I, Beauval N, et al. Comparison of the Chemical Composition of Aerosols From Heated Tobacco Products, Electronic Cigarettes and Tobacco Cigarettes and Their Toxic Impacts on the Human Bronchial Epithelial BEAS-2B cells. J Hazard Mater. 5 janv 2021;401:123417.","DOI":"10.1016\/j.jhazmat.2020.123417"},{"key":"rb26","doi-asserted-by":"crossref","unstructured":"26. Stephens WE. Comparing the Cancer Potencies of Emissions From Vapourised Nicotine Products Including E-Cigarettes With those of Tobacco Smoke. Tob Control. 4 ao\u00fbt 2017;tobaccocontrol-2017-053808.","DOI":"10.1136\/tobaccocontrol-2017-053808"},{"key":"rb27","unstructured":"27. Tobacco Tactics, University of Bath. Heated Tobacco Products [En ligne]. 3 f\u00e9v 2023 [Cit\u00e9 le 02\/06\/2023]. Disponible sur\u00a0: https:\/\/tobaccotactics.org\/article\/heated-tobacco-products\/"},{"key":"rb28","doi-asserted-by":"crossref","unstructured":"28. Caponnetto P, Campagna D, Maglia M, Benfatto F, Emma R, Caruso M, et al. Comparing the Effectiveness, Tolerability, and Acceptability of Heated Tobacco Products and Refillable Electronic Cigarettes for Cigarette Substitution (CEASEFIRE): Randomized Controlled Trial. JMIR Public Health Surveill. 4 avril 2023;9:e42628.","DOI":"10.2196\/42628"},{"key":"rb29","unstructured":"29. PMI Science. Philip Morris International. The Evidence to Date on Smoke-Free Products [En ligne]. [Cit\u00e9 le 02\/06\/2023] Disponible sur\u00a0: https:\/\/www.pmiscience.com\/en\/research\/"},{"key":"rb30","doi-asserted-by":"crossref","unstructured":"30. O\u2019Leary R, Polosa R. Tobacco Harm Reduction in the 21st Century. Drugs and Alcohol Today. 10 sept 2020; 20:219-34.","DOI":"10.1108\/DAT-02-2020-0007"},{"key":"rb31","doi-asserted-by":"crossref","unstructured":"31. Polosa R. Examining the Evidence For the Health Impact of Combustion-Free Products: Progress and Prospects For Tobacco Harm Reversal and Reduction. Intern Emerg Med. 15 sept 2021;16(8):2043-46.","DOI":"10.1007\/s11739-021-02837-2"},{"key":"rb32","doi-asserted-by":"crossref","unstructured":"32. Braznell \u200d S, Van Den Akker A, Metcalfe C, Taylor GMJ, Hartmann-Boyce J. Critical Appraisal of Interventional Clinical Trials Assessing Heated Tobacco Products: A Systematic Review. Tob Control. 8 nov 2022; tobaccocontrol-2022-057522.","DOI":"10.1136\/tc-2022-057522"},{"key":"rb33","unstructured":"33. Jackler RK, Ramamurthi D, Axelrod A, Jung JK, Louis-Ferdinand NG, Reidel JE, et al. Global Marketing of IQOS. The Philip Morris Campaign to Popularize \u201cHeat Not Burn\u201d Tobacco [En ligne]. SRITA White Paper; 2020. 313 p. Disponible sur\u00a0: http:\/\/tobacco.stanford.edu\/iqosanalysis"},{"key":"rb34","doi-asserted-by":"crossref","unstructured":"34. Braznell S, Branston JR, Gilmore AB. Corporate Communication of the Relative Health Risks of IQOS Through a Webchat Service. Tob Control. ao\u00fbt 2022; 32(e2):e205-e211.","DOI":"10.1136\/tobaccocontrol-2021-056999"},{"key":"rb35","doi-asserted-by":"crossref","unstructured":"35. Abroms LC, Wysota CN, Tosakoon S, Khayat A, Duan Z, Bar-Zeev Y, et al. Industry Marketing of Tobacco Products on Social Media: Case Study of Philip Morris International\u2019s IQOS. Tob Control. 16 mars 2023;tc-2022-057833.","DOI":"10.1136\/tc-2022-057833"},{"key":"rb36","unstructured":"36. Code de la sant\u00e9 publique - Articles L3411-7 \u00e0 L3411-10 [En ligne]. Code de la sant\u00e9 publique. Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000031917375\/"},{"key":"rb37","unstructured":"37. PMI Science. What Is Harm Reduction? [En ligne]. 2022 [cit\u00e9 en octobre 2021]. Disponible sur\u00a0: https:\/\/www.youtube.com\/watch?v=H9iHLKzwgww&ab_channel=PhilipMorrisInternational"},{"key":"rb38","doi-asserted-by":"crossref","unstructured":"38. Sy D. Tobacco Industry\u2019s \u201cWellness\u201d Tactic: Ethical Dilemma and Solutions. Tob Prev Cessation. 2023;9:11.","DOI":"10.18332\/tpc\/159119"},{"key":"rb39","unstructured":"39. Commission europ\u00e9enne. Directive d\u00e9l\u00e9gu\u00e9e (UE) 2022\/2100 de la commission du 29 juin 2022 [En ligne]. Union europ\u00e9enne; 2022. 3 p. Disponible sur\u00a0: https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/PDF\/?uri=CELEX:32022L2100"},{"key":"rb40","unstructured":"40. U.S. Food and Drug Administration. FDA Authorizes Marketing of IQOS Tobacco Heating System with \u201cReduced Exposure\u201d Information [En ligne]. 7 juill 2020 [Cit\u00e9 le 02\/06\/2023]. Disponible sur\u00a0: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information"},{"key":"rb41","unstructured":"41. Philip Morris France S.A.S. Communiqu\u00e9 de presse [En ligne]. Philip Morris France S.A.S.; 9 juillet 2020. 3 p. Disponible sur\u00a0: https:\/\/www.datapressepremium.com\/rmdiff\/2009501\/CP-PMF-Decision-FDA-MRTP-juillet2020.pdf"}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:45:31Z","timestamp":1704293131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-sante-publique-2023-5-page-61.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,12,22]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.pr1.0023","relation":{},"ISSN":["0995-3914"],"issn-type":[{"type":"print","value":"0995-3914"}],"subject":[],"published":{"date-parts":[[2023,12,22]]}}}